Name: | eptifibatide |
---|---|
PubChem Compound ID: | 123610 |
Molecular formula: | C35H49N11O9S2 |
Molecular weight: | 831.964 g/mol |
Synonyms: |
188627-80-7; Integrelin; Integrilin; 148031-34-9; 157630-07-4; Eptifibatide; L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-alpha-aspartyl-L-tryptophy-L-prolyl-, cyclic (1-6)-disulfide
|
Name: | eptifibatide |
---|---|
Name (isomeric): | DB00063 |
Drug Type: | biotech |
Synonyms: |
Integrelin; Intrifiban
|
Brand: | Integrilin |
Category: | Anticoagulants, Platelet Aggregation Inhibitors, Antiplatelet Agents |
CAS number: | 188627-80-7 |
Indication: | For treatment of myocardial infarction and acute coronary syndrome. |
---|---|
Pharmacology: |
Eptifibatide is an anti-coagulant that selectively blocks the platelet glycoprotein IIb/IIIa receptor. Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarus barbouri). It belongs to the class of the so called arginin-glycin-aspartat-mimetics and reversibly binds to ...
show more » |
Mechanism of Action: | Eptifibatide inhibits platelet aggregation by reversibly binding to the platelet receptor glycoprotein (GP) IIb/IIIa of human platelets, thus preventing the binding of fibrinogen, von Willebrand factor, and other adhesive ligands. Inhibition of platelet aggregation occurs in a dose- and concentration-dependent manner. |
Protein binding: | Approximately 25% |
Biotransformation: | No major metabolites have been detected in human plasma. Deamidated eptifibatide and other, more polar metabolites have been detected in urine. |
Half Life: | Approximately 2.5 hours |
Clearance: | 55 mL/kg/h [patients with coronary artery disease] |
Toxicity: | Eptifibatide was not lethal to rats, rabbits, or monkeys when administered by continuous intravenous infusion for 90 minutes at a total dose of 45 mg/kg (about 2 to 5 times the recommended maximum daily human dose on a body surface area basis) |
Affected organisms: | Humans and other mammals |
Drug interaction: |
|
---|